Jacqualyn A. Fouse
Director · AGIOS PHARMACEUTICALS, INC.
Individual
- 2025
- Jun 23, 2026
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Jacqualyn A. Fouse files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Herve Hoppenot - $19.77M in INCY purchases and sales in the last 12 months
- Pablo J. Cagnoni - $14.10M in INCY purchases and sales in the last 12 months
- William John Sibold - $10.48M in MDGL purchases and sales in the last 12 months
- Kenneth Bate - $8.03M in MDGL purchases and sales in the last 12 months
- Richard S. Levy - $7.36M in MDGL purchases and sales in the last 12 months
- Steven H. Stein - $6.27M in INCY purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Jacqualyn A. Fouse?
Jacqualyn A. Fouse is a corporate insider, tracked as Director of AGIOS PHARMACEUTICALS, INC. (AGIO). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Jacqualyn A. Fouse last file a Form 4?
The most recent primary Form 4 on record is dated 23 June 2026, one of 4 filings going back to 2025.
